RxDoctor Payments Data

Stephen Savage, MD

Urology · Charleston, SCNPI 1669428553

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (49.0%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 22 manufacturers reported payments, led by Janssen Research & Development, LLC at 36.4% of the total. Among urology clinicians in SC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,792in general payments, 2019–2025

Across 109 payments — averaging $291.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Janssen Research & Development, LLC$12K
  • Intuitive Surgical$8K
  • Merck$4K
  • Boston Scientific$3K
  • Medtronic$1K
  • Tempus AI, Inc$904
  • plus $3K from 16 others
$2,066,624in research payments, 2019–2025

Across 241 payments — averaging $8575.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$1.6M
  • Janssen Research & Development, LLC$388K
  • AstraZeneca$58K
  • Bayer$26K
  • Ferring International Pharmascience Center US$15K
  • Ferring Pharmaceuticals AS$13K
  • plus $10K from 1 others

What the payments were for

  • Consulting fees$15,57349%
  • Travel & lodging$5,49317%
  • Food & beverage$6,72621%
  • Education$4,00013%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,792 in reported general payments places this provider in the 90th percentile of 196 urology providers in South Carolina.

See all urology providers in South Carolina

Medicare billing

Part B allowed, 2024
$243,527
Medicare patients
760
Services billed
2,331

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Thiola EcTiopronin12$91,851
MyrbetriqMirabegron57$34,809
GemtesaVibegron12$14,415
Potassium Citrate ErPotassium Citrate39$4,987
Tamsulosin Hcl277$4,110
Finasteride186$2,412
Methenamine Hippurate32$1,984
Alfuzosin Hcl ErAlfuzosin Hcl23$562
Oxybutynin Chloride ErOxybutynin Chloride19$372
CefuroximeCefuroxime Axetil62$174
Allopurinol11$136
Gabapentin11$42
Ciprofloxacin Hcl11$19

Paid to pharmacies, not to this prescriber.

Other urology in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →